Page last updated: 2024-10-31

mitoxantrone and EHS Tumor

mitoxantrone has been researched along with EHS Tumor in 1 studies

Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.

Research Excerpts

ExcerptRelevanceReference
"i."5.28Hyperthermia enhances mitoxantrone cytotoxicity on human breast carcinoma and sarcoma xenografts in nude mice. ( Mella, O; Roszinski, S; Wagner, T; Weiss, C; Wiedemann, G, 1992)
"i."1.28Hyperthermia enhances mitoxantrone cytotoxicity on human breast carcinoma and sarcoma xenografts in nude mice. ( Mella, O; Roszinski, S; Wagner, T; Weiss, C; Wiedemann, G, 1992)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wiedemann, G1
Mella, O1
Roszinski, S1
Weiss, C1
Wagner, T1

Other Studies

1 other study available for mitoxantrone and EHS Tumor

ArticleYear
Hyperthermia enhances mitoxantrone cytotoxicity on human breast carcinoma and sarcoma xenografts in nude mice.
    International journal of radiation oncology, biology, physics, 1992, Volume: 24, Issue:4

    Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Drug Resistance; Female; Humans; Hypert

1992